» Articles » PMID: 24496073

Oxidative Stress, Testosterone, and Cognition Among Caucasian and Mexican-American Men with and Without Alzheimer's Disease

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2014 Feb 6
PMID 24496073
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The use of testosterone among aging men has been increasing, but results from studies addressing the effectiveness of testosterone replacement therapy have been equivocal.

Objective: Given our prior pre-clinical studies that reported a major influence of oxidative stress on testosterone's neuroprotective effects, we investigated whether the negative effects of testosterone on brain function were predicted by oxidative load.

Methods: In order to test our hypothesis, we determined whether circulating total testosterone and luteinizing hormone correlated with cognition in a subset of the Texas Alzheimer's Research & Care Consortium (TARCC) cohort, consisting of Caucasian (n = 116) and Mexican-American (n = 117) men. We also assessed whether oxidative stress (as indexed by homocysteine levels) modified this relationship between sex hormones and cognition, and whether the levels of two antioxidants, superoxide dismutase-1 and glutathione S-transferase (GST), varied as a function of circulating testosterone.

Results: In a low oxidative stress environment, testosterone was positively associated with the level of the antioxidant, GST, while no deleterious effects on cognitive function were noted. In contrast, under conditions of high oxidative stress (homocysteine levels >12 μmol/L), testosterone and luteinizing hormone were associated with cognitive impairment, but only among Caucasians. The ethnic difference was attributed to significantly higher GST levels among Mexican-Americans.

Conclusion: While testosterone may be beneficial under conditions of low oxidative stress, testosterone appears to have negative consequences under conditions of elevated oxidative stress, but only in Caucasians. Mexican-Americans, however, were protected from any deleterious effects of testosterone, potentially due to higher levels of endogenous antioxidant defenses such as GST.

Citing Articles

Testosterone deficiency worsens mitochondrial dysfunction in APP/PS1 mice.

Zhang T, Chu Y, Wang Y, Wang Y, Wang J, Ji X Front Aging Neurosci. 2024; 16:1390915.

PMID: 38752208 PMC: 11094339. DOI: 10.3389/fnagi.2024.1390915.


Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

Perluigi M, Di Domenico F, Butterfield D Physiol Rev. 2023; 104(1):103-197.

PMID: 37843394 PMC: 11281823. DOI: 10.1152/physrev.00030.2022.


Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm.

Ji W, An K, Wang C, Wang S Hereditas. 2022; 159(1):38.

PMID: 36195955 PMC: 9531459. DOI: 10.1186/s41065-022-00252-x.


The Role of Lipid Rafts and Membrane Androgen Receptors in Androgen's Neurotoxic Effects.

Fadeyibi O, Rybalchenko N, Mabry S, Nguyen D, Cunningham R J Endocr Soc. 2022; 6(5):bvac030.

PMID: 35308305 PMC: 8926069. DOI: 10.1210/jendso/bvac030.


Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress.

Sumien N, Cunningham J, Davis D, Engelland R, Fadeyibi O, Farmer G Endocrinology. 2021; 162(11).

PMID: 34467976 PMC: 8462383. DOI: 10.1210/endocr/bqab185.


References
1.
van den Beld A, Huhtaniemi I, Pettersson K, Pols H, Grobbee D, de Jong F . Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab. 1999; 84(4):1334-9. DOI: 10.1210/jcem.84.4.5616. View

2.
Lovell M, Ehmann W, Butler S, Markesbery W . Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 1995; 45(8):1594-601. DOI: 10.1212/wnl.45.8.1594. View

3.
Luchsinger J, Noble J, Scarmeas N . Diet and Alzheimer's disease. Curr Neurol Neurosci Rep. 2007; 7(5):366-72. DOI: 10.1007/s11910-007-0057-8. View

4.
Cunningham R, Giuffrida A, Roberts J . Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta. Endocrinology. 2009; 150(12):5539-48. PMC: 2795716. DOI: 10.1210/en.2009-0640. View

5.
Bowen R, Smith M, Harris P, Kubat Z, Martins R, Castellani R . Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002; 70(3):514-8. DOI: 10.1002/jnr.10452. View